Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chie Kudo-Saito

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2007
[Current status of gene therapy for cancers]Chie Kudo-Saito
Frontiers in Cell and Developmental Biology|April 18, 2015
Cancer-associated mesenchymal stem cells aggravate tumor progressionChie Kudo-Saito
Oncoimmunology|February 1, 2014
FSTL1 promotes bone metastasis by causing immune dysfunctionChie Kudo-Saito
European Journal of Cancer (Oxford, England : 1990)|May 23, 2016
Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunityChie Kudo-Saito, Takafumi Fuwa, Yutaka Kawakami
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Intratumoral vaccination and diversified subcutaneous/ intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory moleculesChie Kudo-Saito, Jeffrey Schlom, James W Hodge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responsesChie Kudo-Saito, Jeffrey Schlom, James W Hodge
Frontiers in Immunology|October 10, 2022
Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancerChie Kudo-Saito, Narikazu Boku, Hidekazu Hirano, et al.
Cancer Cell|March 3, 2009
Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cellsChie Kudo-Saito, Hiromi Shirako, Tadashi Takeuchi, et al.
Cancer Research|August 23, 2013
Targeting FSTL1 prevents tumor bone metastasis and consequent immune dysfunctionChie Kudo-Saito, Takafumi Fuwa, Kouichi Murakami, et al.
American Journal of Cancer Research|November 16, 2023
IL25<sup>+</sup> macrophages are a key determinant of treatment resistance of IL17RB<sup>+</sup> breast cancerYukinori Ozaki, Keiichi Kinowaki, Hidetaka Kawabata, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2007
[Current status of gene therapy for cancers]Chie Kudo-Saito
Frontiers in Cell and Developmental Biology|April 18, 2015
Cancer-associated mesenchymal stem cells aggravate tumor progressionChie Kudo-Saito
Oncoimmunology|February 1, 2014
FSTL1 promotes bone metastasis by causing immune dysfunctionChie Kudo-Saito
European Journal of Cancer (Oxford, England : 1990)|May 23, 2016
Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunityChie Kudo-Saito, Takafumi Fuwa, Yutaka Kawakami
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Intratumoral vaccination and diversified subcutaneous/ intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory moleculesChie Kudo-Saito, Jeffrey Schlom, James W Hodge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responsesChie Kudo-Saito, Jeffrey Schlom, James W Hodge
Frontiers in Immunology|October 10, 2022
Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancerChie Kudo-Saito, Narikazu Boku, Hidekazu Hirano, et al.
Cancer Cell|March 3, 2009
Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cellsChie Kudo-Saito, Hiromi Shirako, Tadashi Takeuchi, et al.
Cancer Research|August 23, 2013
Targeting FSTL1 prevents tumor bone metastasis and consequent immune dysfunctionChie Kudo-Saito, Takafumi Fuwa, Kouichi Murakami, et al.
American Journal of Cancer Research|November 16, 2023
IL25<sup>+</sup> macrophages are a key determinant of treatment resistance of IL17RB<sup>+</sup> breast cancerYukinori Ozaki, Keiichi Kinowaki, Hidetaka Kawabata, et al.
Pageof 5